4298 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
22 Not yet recruiting The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes
Condition: HIV
Intervention: Behavioral: Peer Support
23 Not yet recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
24 Not yet recruiting An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
25 Not yet recruiting Zambian Peer-Educators for HIV Self-Testing Study
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
26 Recruiting 3BNC117 and 10-1074 in HIV-infected Individuals
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: 3BNC117;   Drug: 10-1074;   Other: Analytical treatment interruption;   Drug: Placebo
27 Recruiting 3BNC117 and 10-1074 in HIV Uninfected Adults
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3BNC117;   Drug: 10-1074;   Drug: Placebo
28 Recruiting Non-Invasive Oral Cancer Screening Among HIV Smokers
Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue;   Human Immunodeficiency Virus
Interventions: Behavioral: Screening Interview;   Device: Carbon Monoxide Test;   Behavioral: Self-Help Materials;   Procedure: Visual Oral Screening Examination;   Procedure: Direct Fluorescent Oral Visualization Examination;   Procedure: Oral Biopsy
29 Recruiting Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Intervention
Conditions: Human Immunodeficiency Virus (HIV) Infection;   Hypercholesterolemia
Interventions: Other: Soy Pretzel;   Other: Wheat Pretzel
30 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
31 Recruiting Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Conditions: Anal Carcinoma;   HIV Infection;   Human Papillomavirus Infection
Interventions: Procedure: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
32 Not yet recruiting Intervention to Encourage HIV Testing and Counseling Among Adolescents
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: HIV prevention videogame
33 Completed Folinic Acid: Supplementation and Therapy
Conditions: HIV Infection;   HCV Coinfection
Interventions: Drug: Folinic Acid;   Drug: Placebo
34 Active, not recruiting Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Dapivirine
35 Completed Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study
Condition: Human Immunodeficiency Virus
Intervention: Other: No intervention
36 Recruiting A Study to Evaluate the Effect of High Fat Meal on Cabotegravir
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Cabotegravir 30 mg
37 Not yet recruiting Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
Conditions: HIV Infection;   Alcohol Use;   Smoking
Interventions: Drug: Varenicline;   Drug: Cytisine;   Drug: Nicotine Replacement Therapy;   Drug: Varenicline Placebo;   Drug: Cytisine Placebo;   Drug: Nicotine Replacement Therapy Placebo
38 Recruiting Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Conditions: HIV Infection;   Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Plasmablastic Lymphoma;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Non-Hodgkin Lymphoma;   Recurrent Burkitt Lymphoma;   Recurrent Follicular Lymphoma;   Stage III Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage IV Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma
Interventions: Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Carmustine;   Drug: Cytarabine;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Biological: Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor Cells;   Drug: Melphalan;   Procedure: Peripheral Blood Stem Cell Transplantation
39 Not yet recruiting Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: VRC01LS
40 Recruiting Impact of ART Adherence on HIV Persistence and Inflammation
Condition: Human Immunodeficiency Virus (HIV).
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years